NEXGEL, INC. Deferred Tax Liabilities, Gross
NEXGEL, INC. (NXGL) had Deferred Tax Liabilities, Gross of $115.00 thousand as of 2020-12-31, per its 10-K filed 2022-03-21.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2022-03-21
- 2020-12-31: Deferred Tax Liabilities, Gross $115.00K.
- 2019-12-31: Deferred Tax Liabilities, Gross $40.00K.
- 2018-12-31: Deferred Tax Liabilities, Gross $17.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2020-12-31 | $115.00K 10-K · filed 2022-03-21 |
| 2019-12-31 | $40.00K 10-K · filed 2021-03-31 |
| 2018-12-31 | $17.00K 10-K/A · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |